Table 3.
ALL | BPD | RYGB | ||||
---|---|---|---|---|---|---|
At study start | At follow-up | At study start | At follow-up | At study start | At follow-up | |
GSG-index | 0.69 ± 0.26 ### | 0.31 ± 0.20 ### | 0.66 ± 0.25 # | 0.34 ± 0.23 # | 0.73 ± 0.29 # | 0.28 ± 0.14 # |
Branched chain amino acids | 1243.65 ± 341.90 ## | 888.37 ± 283.09 ## | 1129.64 ± 199.39 | 981.62 ± 285.96 | 1414.67 ± 453.01 ### | 748.50 ± 233.30 ### |
Aromatic amino acids | 415.81 ± 98.78 | 345.50 ± 117.68 | 397.24 ± 107.24 | 405.40 ± 80.22 ** | 443.67 ± 85.85 # | 255.65 ± 111.07 ** # |
Saturated fatty acids | 5007.40 ± 866.23 | 4501.13 ± 1374.79 | 5282.23 ± 752.38 | 4882.31 ± 1359.03 | 4595.15 ± 924.87 | 3929.37 ± 1297.38 |
** = p-values < 0.01 in comparisons between the BPD group and the RYGB group at study start and follow-up. # = p-values < 0.05, ## = p-values < 0.01 and ### = p-values < 0.001 in comparisons study start vs follow-up in each study group.